• Application Note

Methamphetamines

Methamphetamines

  • Waters Corporation

For forensic toxicology use only.

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief highlights the analysis of methamphetamines using XTerra Columns.   

Introduction

The compounds analyzed in this study are: 

  1. 3,4-methylenedioxyamphetamine (MDA) 
  2. 3,4-methylenedioxymethamphetamine (MDMA)

Experimental

Conditions

Column:

XTerra RP18 3.0 x 100 mm, 3.5 µm

Part number:

186000420

Mobile phase A:

5 mM NH4HCO3, pH 9.6

Mobile phase B:

ACN

Flow rate:

0.6 mL/min

Isocratic mobile phase composition:

80%A; 20%B

Injection volume:

5 µL

Sample concentration:

40 pg/µL

Temperature:

40 °C

Detection:

Fluorescence 280ex 326em

Gain 100 TC = 1s

Instrument:

Alliance 2690, 2475

Compounds

USP Tailing

3,4-methylenedioxyamphetamine (MDA)

0.95

3,4-methylenedioxymethamphetamine (MDMA)

1.10

Results and Discussion

WA20738.065, June 2002

Back To Top Back To Top